Health IT Analytics May 14, 2020
Jessica Kent

NVIDIA has developed new artificial intelligence and genomic sequencing capabilities to help researchers track and treat COVID-19.

To aid COVID-19 research efforts, NVIDIA has developed new artificial intelligence models, genomic sequencing software, and speech recognition technologies for the medical community.

The new capabilities are a major expansion of the NVIDIA Clara healthcare platform, and will help healthcare researchers, technology solutions providers, and hospitals combat the pandemic faster.

“The COVID-19 pandemic has supercharged the collaboration of technology, research and the healthcare industry to develop new computing solutions that accelerate the understanding of the spread, scale and severity of this disease,” said Kimberly Powell, vice president of Healthcare at NVIDIA.

“Never before has there been such a critical need to apply the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Healthcare System, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Public Health / COVID, Technology
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Set Your Team Up to Collaborate with AI Successfully
What’s So Great About Nvidia Blackwell?
Mayo develops new AI tools
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article